SAN FRANCISCO, October 23, 2018 /PRNewswire/ --
The global pharmaceutical sterility testing market size is expected to reach USD 2.0 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a healthy CAGR of 11.8% over the forecast period. Increasing number of drug launches coupled with the rising R&D expenditure across the globe is expected to be the key market growth drivers.
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
Technological advancements in sterility testing methods led to reduction of the procedural time and human intervention, thereby increasing the efficiency and accuracy of these tests. Latest advancements are flexible to suit the safety requirements of innovative products. The FDA also relaxed its regulatory requirements to allow the use of modern sterility tests for ensuring product safety.
Outsourcing of sterility testing is a strategy adopted by many companies in order to reduce cost. Moreover, several contract laboratories are available, which provide quality sterility testing at economic prices. Outsourcing of sterility testing also reduces the need for personnel training, equipment purchases, and manufacturing facility changes.
Regulatory framework for sterile products in pharmacies is increasingly becoming stringent owing to the several adverse events, such as meningitis outbreak (2012), associated with unsafe sterile products compounded in pharmacies. Moreover, the Drug Quality and Security Act provides the FDA authority to monitor and regulate the compounding of drugs, thereby, increasing adoption of sterility testing procedures by the compounding pharmacies.
Developing countries are harmonizing the regulatory framework with ICH standards and are also undertaking initiatives to boost the domestic production by providing incentives and tax concessions. Thus, developing nations are considered to be the future area for expansion of operations and outsourcing of sterility testing by multinational companies.
Browse full research report with TOC on "Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type (In-house, Outsourcing), By Test Type, By End-use, By Sample (Sterile Drugs, Biologics & Therapeutics), And Segment Forecasts, 2018 - 2025" at:https://www.grandviewresearch.com/industry-analysis/pharmaceutical-sterility-testing-market
Further Key Findings From the Report Suggest:
- The outsourcing pharmaceutical sterility testing market is anticipated to register a CAGR of 12.0% over the forecast period
- Among end-users, the others segment includes hospitals, biopharmaceuticals, clinics, and research labs and it is anticipated to witness the maximum CAGR over the forecast period
- Bacterial endotoxin testing segment led the global pharmaceutical sterility testing market with a market share of over 39.0% in 2016
- The North America region is anticipated to expand at CAGR of 11.7% during the estimated period
- Developing countries, especially India and China, are expected to witness a remarkable growth over the coming years
- Some of the key companies in this market are SGS SA; Toxikon, Inc.; Pace Analytical Services, LLC; Boston Analytical; Charles River Laboratories International, Inc.; and Nelson Laboratories LLC.
Browse related reports by Grand View Research:
- Collateral Ligament Stabilizer System Market - The global collateral ligament stabilizer system market size was estimated at USD 1.31 billion in 2016 and is expected to grow at a CAGR of 6.7% over the forecast period.
- Preclinical CRO Market - The global preclinical CRO market size was valued at USD 3.25 billion in 2016 and is expected to grow at a CAGR of 8.3% during the forecast period.
- Bioresorbable Coronary Stents Market - The global bioresorbable Coronary stents market size was estimated at USD 69 million in 2016, which is anticipated to grow at a CAGR of 15% during the forecast period.
- Veterinary Imaging Market - The global veterinary imaging market size was valued at USD 1.86 billion in 2016 and is expected to grow at a CAGR of 6.6% during the forecast period.
Grand View Research has segmented the global pharmaceutical sterility testing market on the basis of type, test type, end-use, sample and region:
- Pharmaceutical Sterility Testing Type Outlook (Revenue, USD Million, 2014 - 2025)
- In-house
- Outsourcing
- Pharmaceutical Sterility Testing Test type Outlook (Revenue, USD Million, 2014 - 2025)
- Sterility Testing
- Bioburden Testing
- Bacterial Endotoxin Testing
- Pharmaceutical Sterility Testing End-use Outlook (Revenue, USD Million, 2014 - 2025)
- Compounding Pharmacies
- Medical Devices Companies
- Pharmaceutical Companies
- Others
- Pharmaceutical Sterility Testing Sample Outlook (Revenue, USD Million, 2014 - 2025)
- Sterile Drugs
- Medical Devices
- Biologics & Therapeutics
- Pharmaceutical Sterility Testing Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
- North America
Explore the BI enabled intuitive market research database,Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
